Opioid Indications Under TGA Scrutiny As Australia Tackles Growing Misuse
The Australian drug regulator is reviewing the indications, pack sizes and information documents for consumers of potent opioid products to see how misuse and overdoses can be prevented.
You may also be interested in...
"At least four" guidances will replace it, Commissioner Gottlieb notes in frank update which states "I don’t want to look back ten years from now and wish there were more policies we had pursued, or more steps we had taken, to stop the advance of this crisis."
Australian regulators are proposing to review the indications of strong opioids to see if they are appropriate, according to one of eight regulatory options for addressing the growing problem of opioid misuse in the country.
The European Medicines Agency wants to make it clearer for drug sponsors what more they can do to address the presence of cancer-causing impurities in active substances, and how to deal with the issue in their regulatory submissions.